Actually.... PR's should be accurate and follow up if not attainable , investors will research companies including vision, announced projects, revenue, timeline. You expect all "Houdini" PR's questioned during conference calls??? How about credible , trustworthy info and reachable goals met or adjusted to avoid ....here we go again ......
Expect Q3 soon , let's hope DJ will clarify the IPO structure within the next couple of weeks.
Remember dilution direct result of lack of funds !!!
Exciting times ahead !!
(1)
(3)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links